Citigroup’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-568,440
Closed -$48.3M 5404
2020
Q3
$48.3M Buy
568,440
+427,194
+302% +$36.3M 0.03% 292
2020
Q2
$5.01M Sell
141,246
-29,779
-17% -$1.06M ﹤0.01% 1088
2020
Q1
$2.31M Buy
171,025
+67,171
+65% +$906K ﹤0.01% 1317
2019
Q4
$2.2M Sell
103,854
-147,924
-59% -$3.13M ﹤0.01% 1610
2019
Q3
$3.34M Sell
251,778
-63,121
-20% -$837K ﹤0.01% 1280
2019
Q2
$4.37M Buy
314,899
+242,059
+332% +$3.36M ﹤0.01% 1171
2019
Q1
$1.4M Sell
72,840
-514,012
-88% -$9.87M ﹤0.01% 1738
2018
Q4
$8.37M Buy
586,852
+413,285
+238% +$5.9M 0.01% 772
2018
Q3
$3.62M Buy
173,567
+39,591
+30% +$825K ﹤0.01% 1170
2018
Q2
$3.17M Sell
133,976
-93,470
-41% -$2.21M ﹤0.01% 1236
2018
Q1
$3.32M Sell
227,446
-262,385
-54% -$3.83M ﹤0.01% 1177
2017
Q4
$7.92M Buy
489,831
+286,748
+141% +$4.63M 0.01% 775
2017
Q3
$2.84M Buy
203,083
+25,568
+14% +$357K ﹤0.01% 1271
2017
Q2
$1.57M Buy
177,515
+162,215
+1,060% +$1.43M ﹤0.01% 1638
2017
Q1
$99K Sell
15,300
-93,404
-86% -$604K ﹤0.01% 3356
2016
Q4
$399K Buy
108,704
+76,963
+242% +$282K ﹤0.01% 3081
2016
Q3
$103K Buy
31,741
+3,211
+11% +$10.4K ﹤0.01% 3392
2016
Q2
$66K Sell
28,530
-77,307
-73% -$179K ﹤0.01% 3563
2016
Q1
$265K Buy
105,837
+52,789
+100% +$132K ﹤0.01% 3253
2015
Q4
$163K Buy
53,048
+41,820
+372% +$129K ﹤0.01% 3218
2015
Q3
$19K Sell
11,228
-12,565
-53% -$21.3K ﹤0.01% 4096
2015
Q2
$96K Sell
23,793
-4,250
-15% -$17.1K ﹤0.01% 3279
2015
Q1
$108K Sell
28,043
-17,704
-39% -$68.2K ﹤0.01% 3360
2014
Q4
$220K Buy
45,747
+16,952
+59% +$81.5K ﹤0.01% 3082
2014
Q3
$107K Buy
28,795
+9,549
+50% +$35.5K ﹤0.01% 3097
2014
Q2
$70K Sell
19,246
-31,227
-62% -$114K ﹤0.01% 3320
2014
Q1
$213K Buy
50,473
+8,357
+20% +$35.3K ﹤0.01% 2814
2013
Q4
$194K Buy
42,116
+11,194
+36% +$51.6K ﹤0.01% 3180
2013
Q3
$191K Buy
30,922
+20,930
+209% +$129K ﹤0.01% 2639
2013
Q2
$55K Buy
+9,992
New +$55K ﹤0.01% 3716